U.S., Sept. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07192666) titled 'Exosomes in Patients With Ocular Involvement of Sjogren's Syndrome' on Sept. 09.
Brief Summary: This study is a single-center, multiple-dosing, prospective, nonrandom, single-arm trial.
Study Start Date: Sept. 15
Study Type: INTERVENTIONAL
Condition:
Sjogren's Syndrome
Intervention:
DRUG: Exosome Preparation
Each subject will have a single designated study eye; this eye will receive multiple instillations-one drop four times daily for 14 consecutive days.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Guangdong ProCapZoom Biosciences Co., Ltd.
Published by HT Digital Content Services with permission from Health Daily Dig...